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The thymus is a central lymphoid organ for the differentiation of T cells. The
thymus contains >95% thymocytes and trace numbers of othercells like macrophages,
dendritic cells, and epithelial cells (1) . Only a small number of Ig+ B cells are de-
tected in normal thymi (1), but expanded numbers have been reported during dis-
ease. B cell follicles and numerous plasma cells have been reported in the thymus
of patients with autoimmune diseases like myasthenia gravis and systemic lupus
erythematosus (2-4), and similar findings have been noted in autoimmune-prone
mice such as (NZB x NZW)Fi, MRL/Mp-lpr/lpr (MRL/lpr), and BXSB (5). In
these pathologic situations, it has not been elucidated if the B cells infiltrate the thymus
from the blood, or if the B cells originally are present in the thymus and expand
as part of the disease.
We have begun a study of thymic B cells to determine their contribution to au-
toantibody formation. We have succeeded in enriching thymic B cells from normal
mice and find that most of these lymphocytes have the unusual phenotype of the
Ly-1 B cell subset, a subset previously implicated in autoantibody production (6, 7).
Materials and Methods
Mice.
￿
Female (BALB/c x DBA/2)F, (CD2F,) and C57BL/6J (B6) mice were purchased
from Japan Clea Corp. (Tokyo) and kept under specific pathogen-free conditions until use
at 6-8 wk of age.
Antibodies.
￿
mAb to Thy-1.2 [F7D5] was purchased from Olac Ltd. (Bicester, United
Kingdom). mAb to Thy-1.2 (30-H12, IgG2b), CD4 (GK 1.5, IgG2b), Lyt-2 .2 or CD8 (HO-
2.2, IgM), B220 or CD45R (RA3-3A1/6.1, IgM; 14-8, IgG2b), Ia (M5/114.15 .2, IgG2b),
and Mac-1 or CDllb (Ml/70, IgG2b) were from the American Type Culture Collection (Rock-
ville, MD). The mAbs were used for depletion or staining. FITC-coupled rabbit anti-mouse
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p-chain F(ab')2 or FITC-rabbit anti-mouse Ig F(ab')2 fragments were obtained from Cappel
Laboratories (West Chester, PA), while biotinated mouse anti-rat Igic mAb was from Zymed
Laboratories (San Francisco, CA). Biotinated anti-Lyt-1 or CD5 (53 .7.3, IgG2a), biotin-anti-
CD8 (53.6.7, IgG2a), FITC-avidin, and PE-avidin were from Becton Dickinson & Co. (Moun-
tain View, CA). F(ab')2 fragment of goat anti-mouse p chain from Cappel Laboratories was
used to stimulate B cells.
Cell Preparation.
￿
The connective tissue attached to thymic lobes was carefully peeled off
to remove the parathymic lymph nodes. Thymocytes were prepared by gentle teasing onto
a fine steel mesh, were washed twice in RPMI 1640 medium (Nissui, Tokyo, Japan), and
suspended in medium with 10% FCS (HyClone Laboratories, Logan, UT). Cell suspensions
were layered onto the 65% Percoll solution (Pharmacia Fine Chemicals, Uppsala, Sweden)
(1) and centrifuged at 900 g for 20 min. The low-density cells (50-60% of the total) at the
interface between the medium and the Percoll solution were collected, washed twice in RPMI
1640, and treated with a mixture ofmAb to Thy-1 .2, CD4, and CD8 (above) in the presence
of rabbit complement. The mAb and dead cells were removed by washing twice in alkaline
(pH 7 .6-7.8) RPMI 1640. The resulting population was B cell enriched and T cell depleted
(see Results). B cells from the spleen were prepared by the same T cell depletion procedure,
with or without passage through Sephadex G10 .
Proliferative Assays.
￿
Triplicate cultures of 10' cells were incubated in 0.2 ml of RPMI 1640
medium containing 10% FCS, penicillin, streptomycin, and 50 pM 2-ME in flat-bottomed
Corning microculture plates. The stimuli were: 25 pg/ml LPS (Escherichia coli 055:85 Difco
Laboratories Inc., Detroit, MI), 2 pg/ml Con A (Pharmacia Fine Chemicals), or anti-p (10
pg/ml) plus rIL-4 or purified BSF-1 (generously donated by Dr. T. Honjo, Kyoto University,
and Dr. K. Kumagai, Tohoku University). Proliferation was measured on the third day by
pulsing with 1 gCi of [3H]thymidine for 10 h.
Cytofuorography.
￿
Cells were suspended in PBS with 2% FCS and 0.05% azide and stained
according to a triple-layer method using rat mAb, biotin-mouse anti-rat Igic, and FITC-avi-
din. The controls were stained with FITC- or PE-avidin without first mAb, or with nonreac-
tive, isotype-matched mAb (see Results). To double label for Ly-1 and surface Ig, the cells
were stained first with FITC-rabbit anti-mouse g chain F(ab')2 fragment followed by normal
rat Ig to block the reactivity of anti-p with the subsequent antibody and to reduce binding
to Fc receptors. Then the cells were stained with biotin-anti-Ly-1 and PE-avidin. Nonreac-
tive control biotin-mAb were to Thy-1 and CD8. The cells were analyzed on a FACStar (B-D
Automated Immunochemistry, Salt Lake City, UT).
Results
Enrichment ofB Cellsfrom Normal Thymus.
￿
To enrich the trace population ofthymic
B cells, suspensions were separated on Percoll density gradients. Most sIg+ thymic
B cells were recovered in the low-density fraction, whereas only a supopulation of
splenic B cells floated under similar conditions. After treatment with a cocktail of
anti-T cell mAb and complement, the frequency of sIg+ B cells rose from -3% to
>90°/ (below). The yield was N1% of the starting thymus suspension .
B cell enrichment was evident by functional assays, i.e., proliferation to LPS and
anti-p plus IL-4. The starting thymocytes, the low-density fraction, and the B cell-en-
riched population were compared (Table I). The latter responded best to LPS, and
to anti-g plus IL-4, but was depleted of Con A reactivity. The low-density cells
(50-60% of the total thymus cells) responded vigorouly to Con A because most im-
munoincompetent thymocytes sedimented (not shown), but weakly to LPS and IL-
4. The high-density population, even when treated with anti-T cell mAb and com-
plement, failed to respond to the B cell stimuli (not shown).
Phenotype ofThymic B Cells.
￿
Cytofluorography was used to compare enriched prepa-
rations of thymic B cells with spleen B cells (Fig. 1) . More than two of three of the* Cells (10) were cultured with or without various kinds of stimulants for 72 h, and pulsed with t3H)TdR
for the last 10 h of the culture period. Numbers in the table represent mean cpm of triplicated cultures .
Cells in each fraction were stained with FITC-conjugated rabbit anti-mouse Ig antibody.
4 Low-density cells were obtained from the upper layer of the 65% Percoll gradient.
~~ B cell-enriched cells were obtained form the low-density cells by treating them with anti-L3T4, anti-Lyt-2.2,
and anti-Thy-1 .2 mAbs plus complement.
thymic B cells coexpressed Lyt-1 (CD5), whereas most splenic B cells were Lyt-1 - .
The thymic B cellscould also be killed with a cytotoxic anti-Lyt-1 mAb (not shown).
Both thymic and splenic B cells had comparable levels of sIg (Fig. 2, a andf), but
most of the thymic B cells had less B220 or CD45R (b vs. g) and la (c vs. h). Mac-1
[CDllb] and CD5 were found on most thymic B cells, which did not react with two
isotype-matched control mAbs, GK1.5 anti-CM and 30-H12 antiThy-1 (d and e).
Discussion
We have been able to enrich the small number of thymic B cells (N 1% of thymic
suspensions) and have found that most have the features of Ly-1 B cells. The latter
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TABLE I
Enrichment of Thymic B Cells
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FIGURE 1 .
￿
Twocolor FRCS analysis of thymic andsplenic B cells. Enriched populations ofthymic
and splenic Bcells were treated successively with FITC-rabbit anti-mouse R chain F(ab')z frag-
ment, excess normal rat IgG, biotin-anti-Lyt-I (CD5), and PE-avidin. The stained cells were
fixed and analyzed on a FACStar cytofluorograph.
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Proliferative responses*
Cells from thymus -
Anti-w
antibody
(10 mg/ml)
IL-4
(10 U/ml)
Anti-4
+
IL-4
cpm
LPS
(25 ug/ml)
Con A
(2 4g/ml)
Ig-bearing
cells,
%
Total cells 892 573 1,574 1,261 643 13,883 0.6
Low-density cellsS 914 577 4,360 3,492 284 71,091 2.7
B cell-enriched cells1l 415 454 2,602 16,541 36,193 2,776 89.9814
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Phenotype of thymic and Splenic B cells. Enriched populations of thymic (tofu) and
splenic (bottom) B cells were stained with the different mAbs indicated on the panel and specified
in Materials and Methods, followed by biotin-mouse anti-rat Igic and FITC-avidin. The desig-
nation [-] on the panels were controls that were unstained cells (a andf), FITC-avidin only (b
and g), and biotin-mouse anti-rat Igic and FITC-avidin (e ands).
are a distinct population of CD11b' and CD5' lymphocytes which are detected in
the peritoneal cavity but are hard to find in spleen, blood, and especially lymph
nodes (6, 7). Similarresults were obtained with thymi of C57BL/6 and young NZB
mice, andfrom C57BL/6 mice varyingin age from 3 to 8wk (not shown). Thestaining
of B cells for CD5 was specific, since no decrease was seen with an excess of rat Ig
(500 wg/ml) to block Fc receptors, and there was no staining with other anti-T cell
mAbs like antiThy-1 CD8 and CD4. Furthermore, the majority of thymic B cells
prepared by ourprocedure could be killed by anti-CD5 (but not antiThy-1.2, CD4,
or CD8) mAb and complement. Other comparisons with conventional splenic B
cells are that the thymic cells had less B220 and la antigens, a lowerbuoyant density
in Percoll, and similar amounts of membrane g. These results are consistent with
those reported for Ly-1' B cells in the peritoneal cavity (8, 9).
Our functional assays demonstrated that thymic B cells responded to B cell
stimulants. However, the responses were much lower than spleen (not shown). In
preliminary studies, Ly-1' thymic B cells have been purified on the FACS and found
to have little or no responsiveness either to LPS or to anti-w and IL-4. Likewise,
depletionwith anti-Ly-1 and complement enhances the responsiveness of the thymic
B cell preparation to these stimuli. Therefore Ly-1 B cells may not contribute to
the functional assays that were used to help monitorourenrichment method (Table I).
Peripheral Ly-1' B cells are known to be involved in "spontaneous" secretion of
IgM, including autoreactive antibody (10). These B cells appear early in develop-
ment (11) and are long lived (12). A regulatory role has been suggested in allotypic
(13) and idiotypic cell-cell interactions (14-16). This being the case, it is possible
that the Ig V region of thymic Ly-1 B cells shapes the repertoire of T cell antigen
receptors by providing epitopes that correspond to antigen in association with self-
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MHC. Alternatively, products of the Ly-1 B cell repertoire may function to elimi-
nate or inactivate self-reactive T cells by providing internal images of self during
T cell development. We are now studying the ontogeny of these thymic B cells to
clarify their function in normal and autoimmune-prone mice.
Summary
A small number of B cells are found in the thymus of normal mice. A population
of B lymphocytes could be enriched to >90% purity by isolating a low-density frac-
tion on Percoll density gradients and then depleting T cells with a mixture of anti-
Thy-1, CD4, and CD8 mAbs and complement. Enrichment was monitored by sur-
face Ig staining and by functional studies (responsiveness to LPS, and to anti-w plus
IL-4). When the phenotype of these B cells was studied by flow cytometry, 60-80%
had the phenotype Ly-1+ (CD5), la', B220' (CD45R), and Mac-1' (CD Ilb). In
contrast, splenic B cells lacked CD5 and CD11b and expressed higher levels of B220
and Ia antigens. These results indicate that most thymic B cells have the phenotype
of the Ly-1 B cell subset, which was identified previously as a trace subpopulation
in some peripheral tissues and is thought to play a role in autoantibody formation.
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